
Why does IRE1 sometimes promote tumors and sometimes fight them?
We identify DPM1 as the rheostat controlling IRE1 activity. Low DPM1 sustains immunogenic IRE1 signaling, enhances CD8+ T-cell surveillance, and predicts better immunotherapy responses. nature.com/articles/s4146…
English










